Denee, Tom
Kerr, Cicely
Richards, Sarah
Dennis, Natalie
Foix-Colonier, Astrid
Fischer, Claire
Larkin, Fintan
Funding for this research was provided by:
Janssen-Cilag Ltd
Article History
Received: 12 September 2023
Accepted: 15 July 2024
First Online: 23 August 2024
Declarations
:
: The CPRD has been granted generic ethics approval for observational studies that make use of only anonymised data and linked anonymised NHS health-care data (Multiple Research Ethics Committee ref. 05/MRE04/87). The current study used patient data from linked CPRD-HES-ONS-MHSDS, which were anonymised prior to release, therefore patients’ informed consent was not required. The use of linked CPRD-HES-ONS-MHSDS data was approved by the CPRD Independent Scientific Advisory Committee (ISAC Protocol No. 19_091R2).
: Not applicable.
: TD, CK, and SR are employees of Janssen, pharmaceutical company of Johnson & Johnson and hold stock options. ND, AFC, and CF are employees of Amaris Consulting. Amaris consulting was contracted by Janssen for the conduct of this study.FL reported honoraria and consulting fees from Janssen and participation in an advisory board for Janssen.